Point72 (Difc) LTD Edwards Lifesciences Corp Call Options Transaction History

Point72 (Difc) LTD

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $3.33 Million - $5.22 Million	55,700 Added 1638.24%	59,100 $3.9 Billion
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $944,160 - $1.06 Million	-11,200 Reduced 76.71%	3,400 $314 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $1.06 Million - $1.4 Million	14,600 New	14,600 $1.4 Billion

1,350

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 (Difc) LTD with notifications on news.